ZURICH/GDANSK, Oct 28 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday:
NOVARTIS NOVN.S
Third quarter results due.
AMRIZE AMRZ.S
Third quarter results due.
LOGITECH LOGN.S
Second quarter results due.
GALENICA GALE.S
Investor day 2025.
SIG GROUP SIGNC.S
Third quarter results due.
TEMENOS TEMN.S
Third quarter results due.
LANDIS+GYR LANDI.S
Half year 2025 results due.
COMPANY STATEMENTS
BUCHER INDUSTRIES BUCN.S
Expects slightly lower sales for 2025 on a comparable basis.
GALDERMA GROUP GALD.S
Secondary offering about 20 million shares, says bookrunner.
NOVARTIS NOVN.S
Defended its $12 billion deal to acquire Avidity Biosciences ahead of the U.S. firm getting late-stage data for its muscle disorder treatment next year, saying it was "an appropriate risk to take".
UBS UBSG.S
Applies for US banking licence in wealth management growth drive.
ANALYSTS' VIEWS
JP Morgan raises Holcim HOLN.S target price to 77 Swiss francs from 72 francs
JP Morgan cuts Sika SIKA.S to "underweight" from "neutral"; cuts target price to 160 Swiss francs from 183 francs
Berenberg initiates coverage of R&S Group Holding RSGN.S with "buy" rating; target price 40 Swiss francs
ECONOMY
No major Swiss economic data scheduled.
(Reporting by Zurich newsroom and Gdansk newsroom)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS